Harbin Medical University Researchers Add New Data to Research in Idiopathic Pulmonary Fibrosis (Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages).

Researchers from Harbin Medical University in China have conducted a study to investigate the pathogenesis of lung cancer (LC) in patients with idiopathic pulmonary fibrosis (IPF) and develop a predictor for detecting IPF patients at risk for LC. The study identified 42 common immune function-related pathogenic genes between IPF and LC and developed a five-gene classifier that can successfully distinguish high-risk IPF patients. The study also revealed that SPP1+ macrophages may promote the progression from IPF to LC and highlighted SPP1 as a critical driver in IPF progression, offering a potential target for therapy in fibrosis. [Extracted from the article]

Copyright of Cancer Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)